Clinical Trials Logo

Lymphedema clinical trials

View clinical trials related to Lymphedema.

Filter by:

NCT ID: NCT03999177 Completed - Breast Cancer Clinical Trials

Pilot Usability and Feasibility Testing on Kinect-Enhanced Training System for Lymphatic Exercises

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Correct performance of therapeutic lymphatic exercises has the potential to relieve lymphedema symptoms and optimize limb volume and lymph fluid level, in turn to improve breast cancer survivors' quality of life and reduce the risk of lymphedema. Kinect-TOLF (Kinect-Enhanced The-Optimal-Lymph-Flow Training System) is an innovative intelligent Kinect-enhanced training system to teach patients to perform the lymphatic exercises correctly. The Kinect-TOLF training system is not a medical device but a computer/mobile and motion-sensor program that helps patients to perform the lymphatic exercises correctly. The Kinect system can automatically detect whether a user is performing the set of lymphatic exercises correctly in real time and provide instantaneous feedback to the user, thus enhancing patients' self-efficacy to perform the lymphatic exercises correctly. The goal of the proposed project is to evaluate the usability and feasibility of Kinect-TOLF.

NCT ID: NCT03992508 Completed - Lymphedema Clinical Trials

Treatment of Breast Cancer-related Lymphoedema

Start date: August 17, 2012
Phase: N/A
Study type: Interventional

To evaluate the role of intermittent pneumatic compression in the treatment of breast cancer-related lymphoedema.

NCT ID: NCT03945838 Completed - Lymphedema Arm Clinical Trials

Assessment of Muscle Strength and Volume Changes in Patients With Breast Cancer- Related Lymphedema

Start date: April 4, 2017
Phase:
Study type: Observational

This study aims to find whether complete decongestive therapy used in breast cancer-related lymphedema has an effect on muscle strength in the affected arm, while assessing the efficacy of the therapy itself. 74 patients with breast cancer related lymphedema were included in this study. Patients were taken their demographic and clinical history and were evaluated with measurements of extremity volumes and hand grip strengths using a hand dynamometer before and after the complete decongestive therapy. Data were then assessed using relevant statistical methods.

NCT ID: NCT03917771 Completed - Sentinel Lymph Node Clinical Trials

Early Detection of Lower Extremity Lymphedema After Lymphadenectomy in Gynecological Cancer

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study aims to detect and treat early lower limb lymphedema secondary to lymphadenectomy with the aim of increasing the quality of life of patients with this chronic condition. To this end, a group of patients (treatment group) will be referred to the Rehabilitation service for a previous consultation and after surgery where lymphedema could be detected early. In addition, the usual follow-up will be carried out in Gynecology Oncology consultation (GO). In the second group, also called control, will be performed the usual follow-up in GO. For this we randomize to one of these two groups. The research project has the favorable report of the Center's Clinical Research Ethics Committee

NCT ID: NCT03856281 Completed - Lymphoedema of Leg Clinical Trials

Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema

IMPRESS II
Start date: July 10, 2018
Phase: N/A
Study type: Interventional

The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression (IPC) represents an innovative treatment for this condition, however the efficacy of IPC as a treatment for lower limb lymphoedema needs to be investigated via robust clinical research.

NCT ID: NCT03825263 Completed - Lymphoedema Clinical Trials

Intermittent Pneumatic Compression for Treating Lower Limb Lymphoedema

IMPRESS
Start date: May 10, 2017
Phase: N/A
Study type: Interventional

The treatment of lymphoedema and its associated complications represent a considerable drain on increasingly limited NHS resources. Intermittent pneumatic compression, specifically the LymphAssist (Huntleigh Healthcare), represents an innovative treatment for this condition but the efficacy of this device needs to be investigated via robust clinical research.

NCT ID: NCT03776721 Completed - Lymphedema Clinical Trials

Treatment of Breast Cancer-related Lymphedema With Stem Cells and Fat Grafting

Start date: December 18, 2018
Phase: Phase 2
Study type: Interventional

Breast cancer-related lymphedema is one of the most common and feared consequences of breast cancer treatment. Currently, lymphedema is primarily addressed conservatively with compression garments. Regenerative medicine may provide a new treatment option for lymphedema. This Phase 3 trial will examine the efficacy, effectiveness and safety of freshly isolated adipose-derived stromal cells administered in conjunction with a fat grafting procedure to the affected axillary region.

NCT ID: NCT03776214 Completed - Clinical trials for Optimal Treatment of Lymphedema

Surgery in Addition to the Medical Treatment of Lymphedema

LYMPHOSPIR
Start date: April 1, 2018
Phase:
Study type: Observational

Lymphedema is a chronic pathology with a real impact on the quality of life of patients. Despite optimal medical management of patients, some patients still have no pitting edema on which the medical treatment has no effect. It is adipose tissue secondary to the evolution of lymphedema. It is often painful and important in terms of volume with the resulting functional consequences. The investigators propose to these patients a surgical management complementary to the optimal medical treatment by microlipoaspiration associated or not with a dermolipectomy. This surgical management began in 2014 in our service. The investigators want to evaluate the impact on quality of life of patients in this surgical management in addition to medical care.

NCT ID: NCT03765996 Completed - Clinical trials for Breast Cancer Lymphedema

Effectiveness of Taping on Anastomotic Regions in Patients With Breast Cancer-Related Lymphoedema

Start date: January 1, 2012
Phase: N/A
Study type: Interventional

One of the most common conservative treatments of lymphoedema is Complex Decongestive Physiotherapy (CDP). The bandage is one of the most important components of the treatment process. The multilayer short-stretch bandage is used to maintain volume reduction and prevent lymph backflow caused by compression. However, some patients refuse or postpone treatment or show a lower compliance with compression bandaging.Kinesio® Tex tape (KT) is a new technique for managing lymphoedema in the field of physical and alternative therapy, and it may affect decongestion of lymphatic fluid accumulated under the skin. Some studies which showed that KT was an effective for patients with BCRL, it was applied on both the affected arm and anastomosis. One of these studies also reported that a significant reduction in limb volume in patients who were applied of the tape only to the affected arm. This significant effect could also be seen by applying KT only to the anastomosis. In literature, however, there is no evidence to support this theory. So the aim of this study is to determine the effectiveness of KT which was applied to anastomotic regions along with CDP in the management of BCRL.

NCT ID: NCT03764943 Completed - Breast Cancer Clinical Trials

Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction

Start date: February 1, 2019
Phase: Phase 3
Study type: Interventional

This study is designed to test the following hypothesis: patients undergoing immediate alloplastic and autologous breast reconstruction following mastectomy that receive preoperative immunonutrition will experience a reduction in wound complications in the 30-day postoperative period compared to a standard of care control group (retrospective chart review) of 264 (132 alloplastic + 132 autologous) consecutive breast reconstruction patients prior to 5/25/2018.